EX-23.1 4 v337844_ex23-1.htm EXHIBIT 23.1

Exhibit 23.1


Consent of Independent Registered Public Accounting Firm



The Board of Directors
Intercept Pharmaceuticals, Inc.:


We consent to the incorporation by reference in the Registration Statement (No. 333-184810) on Form S-8 of Intercept Pharmaceuticals, Inc. of our report dated April 1, 2013, with respect to the consolidated balance sheets of Intercept Pharmaceuticals, Inc. and subsidiary (a development stage enterprise) as of December 31, 2011 and 2012, and the related consolidated statements of operations and comprehensive loss, changes in stockholders' equity, and cash flows for each of the years ended December 31, 2010, 2011, and 2012, and the information included in the cumulative from inception presentation for the period September 4, 2002 (inception) to December 31, 2012, which report appears in the December 31, 2012 annual report on Form 10-K of Intercept Pharmaceuticals, Inc.




New York, New York

April 1, 2013